Research News

Parkinson's Wearable Technology

National Parkinson’s Study Using Wearable Technology

Wednesday, 21 November 2018

Your opportunity to get involved in a clinical study using wearable technology.   Study sites are available in Sydney, Melbourne, Hobart, Adelaide and Brisbane When you see your doctor, they usually ask how you have been. Sometimes it may be hard to remember…

Could the Appendix Play a Role in Parkinson’s?

Monday, 5 November 2018

A new study published in  Science Translational Medicine suggests the appendix may play a key role in the development of Parkinson’s disease. The study, which examined health data from 1.6 million Swedes, found that people who had an appendectomy were 20 percent less…

Genetics and Parkinson’s – PRKN and PINK1 Genes

Monday, 10 September 2018

Learning about genetic risk factors for Parkinson’s can help scientists learn what goes wrong in the disease — even among those without those risk factors — and how they might fix it. Thanks to this strategy, treatments are now in…

Brain

Study’s Measure Parkinson’s Progression

Thursday, 29 March 2018

Two recent papers outline the progression of Parkinson’s disease (PD) movement or motor symptoms in distinct study populations. While these findings do not provide an absolute picture of how one person will progress with PD, the results may help researchers…

Freezing of Gait in Parkinson's disease

Brain Stimulation to Treat Freezing of Gait and Cognition

Monday, 19 March 2018

The sudden inability to move while walking, or feeling like your feet are stuck to the ground, is called “freezing of gait.” This symptom may arise as Parkinson’s disease (PD) progresses, and can lead to stumbling or falling. Unfortunately, current…

Lew Body Dementia

Seizure Medication May Help Lewy Body Dementia

Sunday, 28 January 2018

Lewy Body Dementia (LBD) is a type of dementia — a broad term for a disease of memory, thinking and/or social abilities that is severe enough to interfere with everyday activities. LBD also is a form of atypical parkinsonism, which…

caffeine may have a neuroprotective effect—meaning that people who are regular coffee drinkers are less likely to develop Parkinson's disease (PD)

Caffeine a Potential Marker for Parkinson’s

Monday, 15 January 2018

Millions of people reach for a caffeinated beverage each morning to jumpstart the day. Now, early research indicates that the stimulant that gets people moving also might help diagnose Parkinson’s disease (PD). A recent study published in Neurologyfound that people with Parkinson’s had…

Parkinson's research

LRRK2 Drug Trial Show Promising Results

Monday, 8 January 2018

Denali Therapeutics has announced positive results from its first-in-human LRRK2 inhibitor clinical trial. The trial concluded that the experimental treatment is safe, and showed a greater than 90 percent inhibition of LRRK2 activity at peak drug levels while lowered the LRRK2…